Cantor Fitzgerald and Leerink partners issued rating changes for Replimune Group, Inc. on July 13, 2026.
2 reports, 2 independent
Updated Aug 12
Gone quiet
- Reports
- 2
- Developments
- 2
- Repetition
- 0%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Cantor Fitzgerald and Leerink partners issued rating changes for Replimune Group, Inc. on July 13, 2026.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.Leerink partners and Cantor Fitzgerald issued new rating upgrades for Replimune Group, Inc.1 source
Cantor Fitzgerald lowered its shares rating on Replimune Group, Inc.1 source
Keep exploring
The entities involved
-
Cantor Fitzgerald
American financial services company
-
Leerink partners
U.S. investment bank
Related events
- Cantor Fitzgerald and Citigroup issued rating updates, while MarketBeat reported research notes on Quince Therapeutics.
- Cantor Fitzgerald raised its price target and rating for Supernus Pharmaceuticals, Inc. on September 2, 2026, and the company filed a disclosure with the SEC.
- Cantor Fitzgerald reiterated an overweight rating on CleanSpark shares.
- Cantor Fitzgerald lowered its price target on Zillow stock, while Citigroup also issued rating updates regarding the company.
- Citigroup and Cantor Fitzgerald issued rating updates, while disclosures were required by the SEC.